Work

A real-world pharmacovigilance study of blinatumomab based on the FDA adverse event reporting system

Year: 2025

Type: article

Study design: Observational Study

Source: Expert Opinion on Drug Safety

DOI: 10.1080/14740338.2025.2464070

Authors: Zheng Zhang, Wenhao Guo, Minghao Chen, Qianzhi Yang, Xia Song, Yuping Wang

Institutions: University of Jinan, First Affiliated Hospital of Jinan University, Lanzhou University Second Hospital, Lanzhou University

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Lanzhou University Second Hospital

OpenAlex ID: W4407225535

FWCI:

Cites: 35

Cited by:

Related to: 10